|
|
 |
|
Total Number of Holdings (excluding cash): 51
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$44,179.52 |
2.37% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$43,819.50 |
2.35% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$41,726.77 |
2.23% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$41,483.86 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$40,728.60 |
2.18% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$40,365.00 |
2.16% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$40,131.04 |
2.15% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$39,533.44 |
2.12% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$38,864.14 |
2.08% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$38,745.98 |
2.07% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,594.30 |
2.07% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,481.45 |
2.06% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$38,548.92 |
2.06% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,558.16 |
2.06% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$38,219.50 |
2.05% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$38,306.09 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$38,295.70 |
2.05% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,140.83 |
2.04% |
| Steris Plc |
STE |
G8473T100 |
173 |
$38,016.75 |
2.04% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$37,878.80 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$37,693.35 |
2.02% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$37,708.10 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$37,380.00 |
2.00% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$37,215.02 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$36,718.29 |
1.97% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$36,732.25 |
1.97% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,819.15 |
1.97% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$36,611.92 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$36,696.66 |
1.96% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$36,627.40 |
1.96% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$36,643.02 |
1.96% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,677.16 |
1.96% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$36,472.80 |
1.95% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$36,332.94 |
1.95% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$36,380.21 |
1.95% |
| Waters Corporation |
WAT |
941848103 |
121 |
$36,388.33 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$36,199.80 |
1.94% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$36,136.10 |
1.93% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$35,964.25 |
1.93% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$36,099.50 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$35,963.16 |
1.93% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$35,971.40 |
1.93% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$35,769.96 |
1.92% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$35,842.52 |
1.92% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$35,606.86 |
1.91% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$35,437.29 |
1.90% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$34,279.20 |
1.84% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$34,194.78 |
1.83% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$29,833.59 |
1.60% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$21,167.31 |
1.13% |
| US Dollar |
$USD |
|
7,539 |
$7,538.75 |
0.40% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|